Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WV › Bridgeport › NPI 1184606600
Hospital

United Hospital Center, INC

United Hospital Center, INC was paid $63.26M by Medicaid between Jan 2018 and Dec 2024, across 519 billing codes. Its largest line is 99284, emergency room visit (serious) — 9.1% of everything it billed.

33Billing provider infoUNITED HOSPITAL CENTER, INC
BRIDGEPORT, WV 26330
33aNPI1184606600assigned 11/18/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$63.26M
24GClaims1,600,457
24DCodes billed519
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in West Virginia

Rank by total paid#3 of 26
Median peer was paid$18.33M
This provider vs. median3.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018250,789$16.93M
2019165,781$10.29M
2020327,183$19.25M
2021306,151$7.17M
2022166,329$2.89M
2023216,974$3.47M
2024incomplete167,250$3.27M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.1% 33,467 29,147 $5.77M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 8.7% 14,471 12,485 $5.47M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 5.0% 32,591 29,331 $3.18M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.8% 9,752 8,661 $1.74M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.7% 118,027 91,629 $1.71M
80053 Comprehensive metabolic panel 2.7% 86,113 71,505 $1.71M
J7120 Ringers lactate infusion, up to 1000 cc 1.3% 21,132 16,572 $821K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.3% 6,710 3,665 $816K
84443 Thyroid stimulating hormone (TSH) 1.2% 25,567 23,266 $781K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 1.2% 1,146 1,043 $744K
88305 Level IV - Surgical pathology, gross and microscopic examination 1.1% 11,521 7,470 $726K
96375 Therapeutic injection; each additional sequential IV push 1.1% 17,632 11,940 $712K
507 more codes
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.1% 19,408 $709K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.0% 10,675 $654K
80048 Basic metabolic panel (calcium, ionized) 1.0% 37,315 $653K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.0% 9,788 $650K
71046 Radiologic examination, chest; 2 views 1.0% 15,100 $648K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.0% 2,190 $642K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 10,020 $611K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 6,294 $607K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 38,264 $583K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 3,517 $580K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 16,258 $539K
78815 Positron emission tomography (PET) for limited area imaging <1% 1,131 $536K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 3,987 $508K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 20,374 $489K
87086 Culture, bacterial; quantitative colony count, urine <1% 31,752 $461K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 3,459 $457K
G0378 Hospital observation service, per hour <1% 9,647 $456K
70450 Computed tomography, head or brain; without contrast material <1% 7,195 $452K
84484 <1% 21,895 $449K
80061 Lipid panel <1% 16,442 $445K
96361 Intravenous infusion, hydration; each additional hour <1% 10,321 $444K
87631 <1% 2,759 $437K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 5,696 $421K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 9,237 $421K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 1,323 $417K
81001 <1% 33,625 $414K
82248 <1% 32,821 $395K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 1,949 $385K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 4,044 $385K
93458 <1% 359 $382K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 13,304 $379K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 22,661 $373K
J9271 Injection, pembrolizumab, 1 mg <1% 130 $373K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 7,654 $362K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 8,073 $359K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 2,202 $342K
83690 <1% 17,127 $319K
J0690 Injection, cefazolin sodium, 500 mg <1% 6,634 $307K
85610 <1% 22,820 $303K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 10,072 $302K
93017 <1% 2,447 $297K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 12,199 $297K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 1,173 $293K
72141 <1% 1,522 $293K
88342 <1% 3,794 $290K
J2785 Injection, regadenoson, 0.1 mg <1% 1,855 $279K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,820 $278K
81025 <1% 8,441 $278K
96376 <1% 5,588 $273K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 559 $268K
85027 <1% 14,556 $259K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,148 $243K
83735 <1% 17,411 $237K
59025 Fetal non-stress test <1% 2,851 $236K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 5,969 $224K
97113 <1% 1,475 $220K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 3,956 $219K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 2,547 $215K
71045 Radiologic examination, chest; single view <1% 12,574 $214K
64483 <1% 594 $213K
83036 Hemoglobin; glycosylated (A1C) <1% 10,605 $207K
73564 <1% 6,586 $198K
72110 <1% 5,293 $198K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,732 $193K
70551 Magnetic resonance imaging, brain; without contrast material <1% 867 $188K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 3,114 $183K
87186 <1% 10,115 $181K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 6,559 $177K
72125 Computed tomography, cervical spine; without contrast material <1% 2,876 $176K
41899 Unlisted procedure, dentoalveolar structures <1% 155 $169K
77336 <1% 823 $167K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 793 $164K
83605 <1% 8,999 $163K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,862 $162K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 4,453 $161K
82607 <1% 5,850 $156K
82803 <1% 6,322 $154K
87077 <1% 9,185 $153K
84703 <1% 6,887 $153K
73221 <1% 552 $152K
81003 <1% 9,457 $150K
88304 <1% 1,403 $147K
73130 <1% 4,240 $146K
76770 <1% 2,282 $145K
84100 <1% 12,346 $145K
82728 <1% 7,155 $144K
86140 <1% 14,193 $140K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,053 $135K
85651 <1% 11,775 $133K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 1,134 $131K
73030 <1% 5,327 $131K
36591 <1% 6,090 $128K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,060 $126K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,069 $125K
96417 <1% 1,403 $124K
83880 <1% 4,728 $119K
73110 <1% 3,625 $119K
J3370 Injection, vancomycin hcl, 500 mg <1% 2,480 $114K
76830 Ultrasound, transvaginal <1% 1,056 $111K
84702 <1% 3,039 $110K
85730 <1% 6,031 $109K
93971 <1% 1,984 $106K
76536 <1% 1,221 $105K
36415 Collection of venous blood by venipuncture <1% 24,667 $104K
J1644 Injection, heparin sodium, per 1000 units <1% 4,272 $100K
74018 <1% 3,527 $99K
84439 <1% 5,037 $97K
84466 <1% 5,589 $96K
J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg <1% 62 $96K
73610 <1% 3,715 $93K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,955 $91K
96415 <1% 1,812 $90K
87040 <1% 3,745 $90K
73630 <1% 3,876 $90K
86850 <1% 5,543 $89K
82805 <1% 1,536 $88K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 43,963 $87K
71250 <1% 1,716 $87K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,772 $85K
C1769 Guide wire <1% 1,217 $81K
83540 <1% 6,278 $80K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 6,740 $78K
74178 <1% 443 $76K
64493 <1% 764 $76K
97014 <1% 2,174 $73K
77412 <1% 735 $72K
82550 <1% 4,292 $72K
73502 <1% 3,050 $71K
82565 <1% 4,942 $71K
86803 <1% 2,611 $70K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 540 $68K
82378 <1% 1,353 $67K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,812 $66K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,524 $66K
86480 <1% 830 $65K
80050 General health panel <1% 1,603 $65K
87522 Neg quan hep c or qual rna <1% 807 $65K
20610 <1% 4,979 $65K
99218 <1% 248 $64K
86901 <1% 5,555 $64K
70498 <1% 643 $64K
87081 <1% 2,754 $63K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,701 $63K
70486 <1% 570 $62K
70496 <1% 618 $60K
86900 <1% 5,559 $60K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 5,152 $60K
J2550 Injection, promethazine hcl, up to 50 mg <1% 958 $59K
74019 <1% 1,374 $59K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 48 $59K
76642 <1% 845 $58K
74022 <1% 858 $57K
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 2,243 $56K
87070 <1% 3,169 $55K
J0875 Injection, dalbavancin, 5 mg <1% 18 $55K
82784 <1% 2,254 $55K
73562 <1% 2,212 $52K
86038 <1% 1,740 $52K
86235 <1% 800 $51K
72146 <1% 266 $51K
82570 <1% 3,996 $50K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 697 $49K
J1650 Injection, enoxaparin sodium, 10 mg <1% 4,300 $49K
93880 <1% 502 $49K
66982 <1% 85 $48K
73522 <1% 1,881 $48K
80076 <1% 2,152 $48K
83516 <1% 1,668 $48K
36430 <1% 213 $47K
97161 <1% 984 $47K
72131 <1% 496 $47K
97162 <1% 1,072 $47K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,529 $46K
84153 <1% 1,942 $46K
86300 <1% 1,787 $46K
93970 <1% 484 $46K
87340 <1% 2,012 $46K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 3,452 $46K
83655 <1% 2,422 $45K
72158 <1% 186 $45K
88307 <1% 340 $45K
A9585 Injection, gadobutrol, 0.1 ml <1% 192 $44K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,636 $43K
73620 <1% 1,492 $43K
72170 <1% 1,339 $43K
77066 Tomosynthesis, mammo <1% 332 $43K
72050 <1% 948 $43K
C9290 Injection, bupivacaine liposome, 1 mg <1% 459 $43K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 469 $43K
96367 <1% 2,209 $42K
76801 <1% 485 $42K
73590 <1% 1,553 $42K
86706 <1% 2,018 $41K
85379 <1% 2,090 $41K
82043 <1% 3,006 $40K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 2,895 $40K
64484 <1% 122 $40K
62323 <1% 849 $40K
82746 <1% 1,823 $39K
96368 <1% 362 $39K
96416 <1% 181 $38K
70491 <1% 70 $37K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 279 $37K
84436 <1% 794 $37K
96411 <1% 339 $36K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 619 $36K
83970 <1% 852 $36K
87205 <1% 2,973 $36K
J3475 Injection, magnesium sulfate, per 500 mg <1% 2,459 $35K
73080 <1% 1,200 $35K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 901 $34K
73120 <1% 1,251 $34K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,963 $34K
A9578 Injection, gadobenate dimeglumine (multihance multipack), per ml <1% 2,225 $34K
90715 <1% 953 $33K
86704 <1% 1,154 $33K
74183 <1% 64 $33K
64635 <1% 394 $32K
86160 <1% 734 $32K
73560 <1% 884 $32K
73090 <1% 1,012 $31K
11045 <1% 36 $31K
82140 <1% 1,755 $31K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 797 $31K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 504 $31K
72100 <1% 986 $30K
85007 <1% 1,422 $30K
J0692 Injection, cefepime hydrochloride, 500 mg <1% 1,541 $30K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 79 $29K
88185 <1% 285 $29K
83615 <1% 1,260 $29K
86255 <1% 996 $28K
82977 <1% 797 $28K
G0475 Hiv antigen/antibody, combination assay, screening <1% 986 $28K
20611 <1% 1,448 $27K
97597 <1% 900 $27K
J1030 Injection, methylprednisolone acetate, 40 mg <1% 1,362 $26K
J8501 Aprepitant, oral, 5 mg <1% 539 $26K
87075 <1% 1,554 $25K
J2704 Injection, propofol, 10 mg <1% 14,141 $25K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 72 $25K
86200 <1% 1,013 $25K
84460 <1% 1,080 $25K
84156 <1% 1,453 $25K
78264 <1% 113 $25K
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 922 $24K
77065 Tomosynthesis, mammo <1% 264 $24K
72052 <1% 377 $23K
86431 <1% 1,259 $23K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 854 $23K
J2469 Injection, palonosetron hcl, 25 mcg <1% 1,261 $23K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 3,007 $23K
72195 <1% 67 $22K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 88 $21K
64721 <1% 64 $21K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 709 $21K
84481 <1% 568 $21K
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries <1% 158 $21K
86376 <1% 587 $20K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 264 $20K
88341 <1% 334 $20K
84550 <1% 1,720 $20K
P9016 Red blood cells, leukocytes reduced, each unit <1% 142 $19K
88300 <1% 217 $19K
0099U <1% 23 $18K
80164 <1% 745 $18K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 12 $18K
J1335 Injection, ertapenem sodium, 500 mg <1% 149 $18K
84520 <1% 1,010 $18K
72072 <1% 494 $17K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 103 $17K
84450 <1% 882 $17K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,505 $17K
84146 <1% 325 $17K
78306 <1% 71 $17K
76870 <1% 163 $17K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,237 $16K
99213 Doctor's office visit, returning patient (routine) <1% 1,390 $16K
86790 <1% 692 $16K
83883 <1% 428 $15K
86920 <1% 280 $15K
94060 <1% 434 $15K
87209 <1% 421 $15K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 5,323 $14K
86618 <1% 716 $14K
73600 <1% 314 $14K
73060 <1% 437 $14K
88142 <1% 642 $14K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 365 $14K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 47 $14K
J1756 Injection, iron sucrose, 1 mg <1% 457 $13K
84145 <1% 598 $13K
87324 <1% 409 $13K
86592 <1% 504 $13K
73140 <1% 350 $13K
12001 <1% 132 $12K
93923 <1% 228 $12K
76882 <1% 323 $12K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 2,106 $12K
J2060 Injection, lorazepam, 2 mg <1% 987 $12K
87210 <1% 448 $12K
87177 <1% 421 $12K
82247 <1% 270 $12K
82009 <1% 208 $11K
72040 <1% 303 $11K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 272 $11K
73552 <1% 429 $11K
84403 <1% 211 $10K
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 407 $10K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 172 $10K
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 187 $10K
86703 <1% 213 $10K
73100 <1% 168 $10K
72084 <1% 223 $10K
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries <1% 120 $9K
97116 <1% 878 $9K
J0780 Injection, prochlorperazine, up to 10 mg <1% 796 $9K
73070 <1% 157 $9K
62321 <1% 51 $9K
78227 <1% 49 $9K
93225 <1% 195 $9K
84165 <1% 429 $9K
77334 <1% 38 $9K
Q3014 Telehealth originating site facility fee <1% 951 $9K
43235 <1% 79 $8K
93226 <1% 181 $8K
96523 <1% 531 $8K
88184 <1% 289 $8K
82105 <1% 204 $8K
86812 <1% 112 $8K
72202 <1% 245 $7K
77080 <1% 97 $7K
74221 <1% 52 $7K
J0640 Injection, leucovorin calcium, per 50 mg <1% 109 $7K
83010 <1% 92 $7K
29580 <1% 63 $7K
G0299 Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes <1% 269 $7K
82310 <1% 617 $6K
87506 <1% 33 $6K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 252 $6K
87045 <1% 200 $6K
J1040 Injection, methylprednisolone acetate, 80 mg <1% 483 $6K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 221 $6K
V2632 Posterior chamber intraocular lens <1% 242 $6K
73501 <1% 117 $6K
12002 <1% 56 $6K
86147 <1% 52 $6K
87046 <1% 200 $6K
82172 <1% 83 $6K
86708 <1% 51 $6K
82010 <1% 450 $5K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 202 $5K
92134 <1% 559 $5K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 190 $5K
J7324 Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose <1% 89 $5K
36416 <1% 493 $5K
10060 <1% 49 $5K
29125 <1% 29 $5K
88313 <1% 127 $5K
67028 Intravitreal injection of a pharmacologic agent <1% 243 $5K
87493 <1% 121 $5K
80051 <1% 462 $5K
71101 <1% 112 $5K
82390 <1% 129 $5K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 533 $4K
76819 Fetal biophysical profile; without non-stress testing <1% 19 $4K
A9561 Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries <1% 122 $4K
82947 <1% 309 $4K
82103 <1% 104 $4K
73000 <1% 105 $4K
90686 <1% 244 $4K
85046 <1% 234 $4K
72074 <1% 111 $4K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 51 $3K
83993 <1% 111 $3K
87147 <1% 165 $3K
95165 Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials <1% 106 $3K
69210 <1% 166 $3K
J1815 Injection, insulin, per 5 units <1% 1,351 $3K
J1453 Injection, fosaprepitant, 1 mg <1% 132 $3K
88173 <1% 25 $3K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 18 $3K
80179 <1% 133 $3K
99214 Doctor's office visit, returning patient (more involved) <1% 222 $3K
82150 <1% 47 $3K
94729 <1% 220 $3K
C1755 Catheter, intraspinal <1% 2,529 $3K
86334 <1% 74 $3K
97035 <1% 51 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,722 $3K
77417 <1% 28 $3K
J9045 Injection, carboplatin, 50 mg <1% 153 $3K
87641 <1% 107 $3K
93308 <1% 89 $2K
84478 <1% 82 $2K
81015 <1% 27 $2K
80055 <1% 67 $2K
82951 <1% 40 $2K
77061 <1% 26 $2K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 166 $2K
83521 <1% 229 $2K
92567 <1% 448 $2K
82952 <1% 40 $2K
86665 <1% 44 $2K
99203 Doctor's office visit, new patient (routine) <1% 194 $2K
51798 <1% 1,465 $2K
80069 <1% 845 $2K
87481 <1% 12 $2K
94726 <1% 160 $2K
86308 <1% 84 $2K
94660 <1% 52 $2K
J1940 Injection, furosemide, up to 20 mg <1% 425 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 6,264 $2K
74021 <1% 76 $2K
J3490 Unclassified drugs <1% 10,670 $2K
83001 <1% 30 $1K
71271 <1% 34 $1K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 14 $1K
92557 <1% 129 $1K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 19 $1K
81206 <1% 13 $1K
87106 <1% 29 $1K
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg <1% 156 $1K
S0077 Injection, clindamycin phosphate, 300 mg <1% 367 $1K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 339 $1K
89051 <1% 41 $1K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 12 $1K
87338 <1% 46 $1K
96377 <1% 19 $1K
76942 <1% 152 $1K
84132 <1% 103 $1K
86762 <1% 18 $1K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 45 $1K
86664 <1% 29 $1K
G0379 Direct admission of patient for hospital observation care <1% 41 $980.41
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 551 $926.26
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 200 $864.48
12011 <1% 13 $842.00
75635 <1% 16 $811.14
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 16 $785.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 142 $755.79
87176 <1% 35 $684.69
92587 <1% 12 $659.85
86617 <1% 24 $645.63
86709 <1% 13 $631.87
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 12 $624.47
88112 <1% 50 $609.04
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 730 $588.31
97535 Self-care/home management training, each 15 minutes <1% 300 $529.68
86364 <1% 57 $491.08
84480 <1% 16 $483.15
74230 <1% 12 $478.25
86341 <1% 15 $422.24
G0260 Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography <1% 16 $409.64
51702 <1% 231 $388.46
87076 <1% 46 $384.63
72192 <1% 13 $378.12
74250 <1% 18 $373.42
87015 <1% 89 $372.54
87329 <1% 26 $360.97
86705 <1% 16 $358.45
74220 <1% 12 $339.78
84402 <1% 15 $335.74
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 505 $280.18
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 52 $279.65
74420 <1% 18 $259.38
83520 <1% 17 $245.13
90656 <1% 38 $239.04
84681 <1% 14 $235.41
92136 <1% 60 $231.28
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 15 $222.63
97016 <1% 27 $201.34
J3480 Injection, potassium chloride, per 2 meq <1% 68 $178.10
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 213 $152.48
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 552 $144.48
94760 <1% 684 $143.30
J3411 Injection, thiamine hcl, 100 mg <1% 40 $134.53
72070 <1% 14 $129.42
90653 <1% 26 $119.71
93242 <1% 37 $115.89
G0008 Administration of influenza virus vaccine <1% 14 $95.84
J1010 Injection, methylprednisolone acetate, 1 mg <1% 32 $85.96
J3260 Injection, tobramycin sulfate, up to 80 mg <1% 15 $65.15
86780 <1% 12 $61.20
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml <1% 263 $56.30
90694 <1% 17 $37.75
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program <1% 1,335 $35.41
82077 <1% 286 $34.88
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg <1% 20 $31.40
85018 <1% 14 $26.58
82962 <1% 40 $14.75
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 56 $13.89
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg <1% 104 $13.43
J1171 Injection, hydromorphone, 0.1 mg <1% 83 $8.06
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 44 $7.11
J7609 Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg <1% 23 $6.00
C1726 Catheter, balloon dilatation, non-vascular <1% 13 $5.17
Q9960 High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml <1% 290 $2.72
C9113 Injection, pantoprazole sodium, per vial <1% 104 $0.39
C1760 Closure device, vascular (implantable/insertable) 0% 15 $0.00
C9257 Injection, bevacizumab, 0.25 mg 0% 16 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 19 $0.00
A4649 Surgical supply; miscellaneous 0% 31 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 40 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 257 $0.00
Q0240 Injection, casirivimab and imdevimab, 600 mg 0% 74 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPLYWACZYNSKI, RUSSELL (VP FINANCE)
Same official

Other billing entities under PLYWACZYNSKI, RUSSELL

Full network →
ProviderLocationPaid
United Hospital Center, INC.Bridgeport, WV$13.72M
United Hospital CenterBridgeport, WV$1.51M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.